Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Jim B who wrote (2374)	7/1/1998 9:02:00 PM
From: Profiteer	Read Replies (1) \| Respond to of 5402

You know Jim, I think some of these folks might be addicted to seeing their own words appear on their monitors! Why else would they keep engaging these assholes with useless conversation..?

To: Jim B who wrote (2374)	7/1/1998 10:04:00 PM
From: Mr. Forthright	Read Replies (3) \| Respond to of 5402

JimB, don't be so cocky. The fact that a couple dozens people answer your silly promotional posts doesn't give you credibility in the eyes on the hundreds who read the threads you write on. Any comments on the valuation model? I am still waiting for hard facts. Why are you not providing those much needed numbers, oh you biotech stock guru with a big $15,000 portfolio? Could you comment on the following. I thought I would share some facts with our fellow SGNC thread participants. Did you know it takes 12 years on average for an experimental drug to go from the laboratories to the actual approved use of the product? Did you know that only 5 in 5,000 compounds that enter preclinical testing make it to human testing? Did you know that only 1 of these 5 will get approved? Did you know that according to a 1993 report from the Congressional Office of Technology Assessment it costs on average $359 million to develop a new drug? Did you know that it takes about 8.5 years for a drug to get approved once it enters human clinical trials? I can hear you say: "but the stock will move before that because it is a big market" to which I respond: sure the stock will progressively go up as (and if) the company clears all these hurdles and obtains the required financing, through equity or partnerships. Don't hype SGNC JimB you are not doing yourself a favor. What you need to do is show clearly the road ahead and how the company will perform. You need to build your credibility by demonstrating that you know the industry and telling investors about the risks and the rewards. Real investors don't want to be told that the stock will go up tomorrow because Forthright will cover his short position. They want to be educated and be put in a situation where they can understand the potential and clearly define and evaluate the risks. SGNC will succeed or fail regardless of you. I do believe in "telling the story". It helps refinance at better terms, and we all know that biotech companies are capital hungry. But I object to your techniques and those of your colleagues. I object to you telling people not to do their homework. Don't insult people like that. As far as your suggestion that if YOU decided to do a valuation model people would take part in it, why don't we join forces and help your followers? How can you refuse to help your friends?